S. 1227 · 116th Congress
Prescription Pricing for the People Act of 2019
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
GrassleySponsor8 cosponsors · 3 D, 5 R
D
Blumenthal
MC
D
Cantwell
SD
R
Daines
JE
R
Ernst
JL
R
Lankford
TT
R
Tillis
MB
R
Blackburn
SW
D
Whitehouse5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Prescription Pricing for the People Act of 2019 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs.
What it does: CRS summary · Reported to Senate · Jun 28, 2019
Prescription Pricing for the People Act of 2019
This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Prescription Pricing for the People Act of 2019
Latest action (Jun 28, 2019): Placed on Senate Legislative Calendar under General Orders. Calendar No. 131.
Policy area: Commerce · Origin: Senate · Introduced: Apr 29, 2019
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.